Signal Genetics Releases Results of Study on Previstage GCC
Signal Genetics has reported the results the study “Guanylyl Cyclase C (GCC) Lymph Nodes (LN) Classification as a Prognostic Marker in Patients with Stage II Colon Cancer: A Pooled Analysis.”
Read More